Filana Therapeutics, Inc. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Filana Therapeutics, Inc. stock issued during period, value, new issues for the quarter ending 2021-03-31 was $189.82M.
- Filana Therapeutics, Inc. stock issued during period, value, new issues for fiscal 2022 was $47.33M, a 75.07% decline from fiscal 2021.
- Filana Therapeutics, Inc. stock issued during period, value, new issues for fiscal 2021 was $189.82M, a 170.21% increase from fiscal 2020.
- Filana Therapeutics, Inc. stock issued during period, value, new issues for fiscal 2020 was $70.25M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2022-12-31 | $47.33M 10-K · filed 2025-03-03 | |
| 2021-12-31 | $189.82M 10-K · filed 2024-02-28 | |
| 2021-03-31 | $189.82M 10-Q · filed 2022-11-07 | |
| 2020-12-31 | $70.25M 10-K · filed 2023-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |